Spinal Modulation, Inc. provides medical devices research and development services. The company is based in Menlo Park, California.
According to the 2002 Health Assessment on the Prevalence of Chronic Pain, severe chronic pain, as defined by the International Association for the Study of Pain, is prevalent in 10 to 13% of the adult population. Limited treatment options exist for these patients and the burden to the healthcare system is unsustainable.
The Spinal Modulation AxiumTM Neurostimulator System is a next-generation intraspinal neuromodulation therapy that stimulates the dorsal root ganglion (DRG) to provide a new pain management option. It has shown promising results in managing chronic intractable leg pain, as well as difficult-to-target anatomy such as the back and foot.
By stimulating the DRG, therapy can be adjusted to cover either broad or specific areas of pain throughout the torso and legs, while limiting uncomfortable postural effects typically experienced with other spinal cord stimulators.
Funding Rounds (5) - $111.3MUpdate
St. Jude Medical develops medical technology and services that focus on putting more control into...
DeNovo Ventures was formed in 2000 by seasoned investors and experienced medical device...
DFJ InCube Ventures is a life science venture capital firm focused on investing in extraordinary...
EPlanet Capital is a venture and growth investor focusing on telecom, media, and technology (TMT)...
Medtronic develops and manufactures innovative medical device technologies and therapies to treat...
Venture capital subsidiary
Venture Capital Firm
Identifies and invests in new medical technologies and the entrepreneurs developing them to...
1135 O'Brien DR
Menlo Park, CA 94025